Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 26,450 shares at $20.39 ($506K) on 2022-11-11, disclosed to the SEC on 2022-11-14.
Open-market sale of $506k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.91 | 14,000 | $251K | 49.6% |
| 2 | $20.10 | 1,800 | $36K | 7.2% |
| 3 | $20.39 | 4,452 | $91K | 17.9% |
| 4 | $20.39 | 4,452 | $91K | 17.9% |
| 5 | $21.41 | 1,625 | $35K | 6.9% |
| 6 | $22.20 | 121 |
| $3K |
| 0.5% |
| Total | $19.13 avg | 26,450 | $506K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |